| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |